By Mill Chart
Last update: Feb 3, 2025
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if HALOZYME THERAPEUTICS INC (NASDAQ:HALO) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted HALOZYME THERAPEUTICS INC showing up in our growth with base formation screen, so it may be worth spending some more time on it.
ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:HALO scores a 9 out of 10:
ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:HALO, the assigned 7 for health provides valuable insights:
ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:HALO scores a 7 out of 10:
ChartMill takes into account not only the Technical Rating but also assigns a Setup Rating to each stock. This rating, on a scale of 0 to 10, reflects the degree of consolidation observed based on short-term technical indicators. Currently, NASDAQ:HALO exhibits a 7 setup rating, indicating its consolidation status in recent days and weeks.
HALO has an excellent technical rating and also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 57.54. Right above this resistance zone may be a good entry point. Very recently a Pocket Pivot signal was observed. This is another positive sign.
More Strong Growth stocks can be found in our Strong Growth screener.
Our latest full fundamental report of HALO contains the most current fundamental analsysis.
Check the latest full technical report of HALO for a complete technical analysis.
This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
NASDAQ:HALO (3/5/2025, 9:44:08 AM)
59.57
+1.43 (+2.46%)
Find more stocks in the Stock Screener
Based on a technical and fundamental analysis of NASDAQ:HALO we conclude: HALOZYME THERAPEUTICS INC (NASDAQ:HALO)—A High-Growth Stock Gearing Up for Its Next Upward Move.
HALOZYME THERAPEUTICS INC could be undervalued. NASDAQ:HALO is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced.
Discover HALOZYME THERAPEUTICS INC, an undervalued stock. NASDAQ:HALO showcases solid financial health and profitability while maintaining an appealing valuation.